Arcus Biosciences (RCUS) Cash & Equivalents Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | 4.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.69% |
| Dec 31, 2025 | 48.00% |
| Sep 30, 2025 | 18.41% |
| Jun 30, 2025 | 58.97% |
| Mar 31, 2025 | 3.78% |
| Dec 31, 2024 | 18.11% |
| Sep 30, 2024 | 9.24% |
| Jun 30, 2024 | -32.17% |
| Mar 31, 2024 | -22.27% |
| Dec 31, 2023 | -38.35% |
| Sep 30, 2023 | -15.60% |
| Jun 30, 2023 | -15.75% |
| Mar 31, 2023 | -56.65% |
| Dec 31, 2022 | 39.19% |
| Sep 30, 2022 | 21.49% |
| Jun 30, 2022 | -14.82% |
| Mar 31, 2022 | 40.68% |
| Dec 31, 2021 | -14.66% |
| Sep 30, 2021 | -19.12% |
| Jun 30, 2021 | 12.38% |